Astec LifeSciences launches Adi Godrej Center for Chemical Research and Development
12 April 2023, Mumbai: Astec LifeSciences Limited, a subsidiary of Godrej Agrovet Limited (GAVL), today launched its new advanced research and development (R&D) Center in Rabale, Maharashtra. Named the ‘Adi Godrej Center for Chemical Research and Development’, the facility will focus on leading-edge innovation and developing sustainable & safe solutions for people and the environment, and providing services to innovator companies in contract development & manufacturing space (CDMO).
Focused on new product generation, process optimization & scale-up along with product life-cycle management, the R&D Center will catalyze Godrej Group’s ambition to be an application-agnostic partner of choice for innovator companies in the rapidly growing chemical industry.
The state-of-the-art R&D Center is equipped with a synthesis lab for product synthesis and a formulation lab to develop new formulations in the crop protection space. Supported by advanced analytical instruments to drive R&D, the center also houses sophisticated process safety infrastructure to undertake safe and sustainable chemical reactions.
Given its capabilities, the new R&D Center will enable the company to develop a newer range of sustainable products at a faster pace and a greater scale, thereby adding value to its customers’ businesses, without compromising on ethics, safety, and care for the environment.
Commenting on the launch, Nadir Godrej, Chairman, GAVL said, “The launch of the R&D Center in Rabale is a significant milestone for Astec LifeSciences in our quest to tap immense potential in the chemical industry. Designed to be a hub of cutting-edge research and development, equipped with state-of-the-art facilities and staffed by some of the brightest minds in the field, at Godrej, we continue to foster curiosity and a culture of innovation. A testament to our commitment to offering advanced solutions with a focus on green chemistry and sustainability, I am happy that our R&D capability and world-class infrastructure will add value for our stakeholders, employees, and customers.”
Emphasizing the need to invest in setting up a new R&D Center, Balram Singh Yadav, Managing Director, GAVL said, “India is an emerging frontier in the chemicals space. However, harnessing its full potential will require an enabling ecosystem and that’s where this R&D Center comes in. The potential in this sector, not just domestically but also globally is huge, and we are confident that our R&D capabilities and the backing of the trusted Godrej brand will make us future-ready and position us at the very cutting edge of the sector.”
Highlighting the potential benefits for its clients and company, Anurag Roy, Chief Executive Offer, Astec LifeSciences Ltd. said, “The CDMO market for chemicals in India is expected to grow at a CAGR of 12% as against the global rate of 10%. This underlines the incredible potential in this sector, and it is herein our new facility will enable us to expand our offerings specifically in the CDMO space. Equipping us to tap on new opportunities, will also make us a partner of choice through our improved ability to provide end-to-end solutions to our customers – from the R&D stage to development to the commercialization of products. Slashing the time-to-market for innovative solutions, we are confident that by improving product development, providing access to advanced equipment and facilities, fostering collaboration, and driving innovation, the new R&D Center will cement us at the right place in the sector at the right time.”
(For Latest Agriculture News & Updates, follow Krishak Jagat on Google News)
